Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

The LUMINA Study

Graciela S. Alarcon, MD, MPH  |  April 13, 2011

Impact beyond lupus in U.S. Hispanics

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Diagnostic CriteriaPathogenesispatient careSystemic lupus erythematosusTreatment

Treat Rheumatoid Arthritis to Target

Elana J. Bernstein, MD; Allan Gibofsky, MD, JD  |  April 13, 2011

The time has come for goal-directed management of RA

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:disease managementResearchRheumatoid Arthritis (RA)Treat-to-Target

Opioids More Dangerous than other Analgesics for Elderly

Sue Pondrom  |  April 13, 2011

Safety events vary among different opioids

Filed under:AnalgesicsDrug UpdatesResearch Rheum Tagged with:NSAIDsOpioidsPainResearchSafetySteroids

Behind the Digital Door

Catherine Kolonko  |  April 13, 2011

Rheumatology practices work toward becoming “meaningful users” of EHRs

Filed under:EMRsPractice SupportTechnology Tagged with:Centers for Medicare & Medicaid Services (CMS)electronic health recordLegislationMeaningful use

A View of Industry from the Inside

Mary Pinkowish  |  April 13, 2011

Rheumatologists with pharmaceutical careers discuss the path that led them to industry and the work they do

Filed under:Career DevelopmentProfessional TopicsWorkforce Tagged with:Career developmentIndustryrheumatologist

Drug UPDATES

Michele B. Kaufman, PharmD, BCGP  |  March 18, 2011

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsFDASafety

He Taught Us to Always Go Deeper

Gretchen Henkel  |  March 18, 2011

Eng Tan, MD, promotes translation from bench to bedside

Filed under:Practice SupportProfilesResearch Rheum Tagged with:CareerResearchSystemic lupus erythematosusTraining

Patient-Driven Care

Vanessa Caceres  |  March 18, 2011

Lupus patient becomes international advocate for better education and care in her home country

Filed under:ConditionsProfilesSystemic Lupus Erythematosus Tagged with:patient carerheumatologistSystemic lupus erythematosus

A Catalyst for Antiphospholipid Syndrome Research

By Neil Canavan  |  March 18, 2011

APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)autoimmune disorderclinical trialsHughes Syndrome

Are NSAIDS Even Less Safe Than We Thought?

Mary Desmond Pinkowish  |  March 18, 2011

Recent meta-analysis points to MI risks, but many questions remain

Filed under:AnalgesicsDrug Updates Tagged with:Cardiovascular diseaseDrugsNSAIDPainrheumatologiststroke

  • « Previous Page
  • 1
  • …
  • 294
  • 295
  • 296
  • 297
  • 298
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences